{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:30:01Z","timestamp":1788604201152,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/md.0b013e31829cae47","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T12:43:45Z","timestamp":1371818625000},"page":"217-222","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence of the Antiphospholipid Syndrome and Its Effect on Survival in 679 Chinese Patients With Systemic Lupus Erythematosus"],"prefix":"10.1097","volume":"92","author":[{"given":"Chi Chiu","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak To","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Yin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Hung","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210226","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/jaut.2000.0402","article-title":"Long-term prognosis of antiphospholipid syndrome in patients with systemic lupus erythematosus.","volume":"15","author":"Alarcon-Segovia","year":"2000","journal-title":"J Autoimmun"},{"key":"R3-4-20210226","first-page":"1067","article-title":"Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.","volume":"21","author":"Drenkard","year":"1994","journal-title":"J Rheumatol"},{"key":"R4-4-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating ClinicsAmerican College of Rheumatology damage index for systemic lupus erythematosus.","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R5-4-20210226","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1160\/TH09-01-0013","article-title":"The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.","volume":"102","author":"Gohil","year":"2009","journal-title":"Thromb Haemost"},{"key":"R6-4-20210226","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R7-4-20210226","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2257.2006.00757.x","article-title":"Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.","volume":"28","author":"Jun","year":"2006","journal-title":"Clin Lab Haematol"},{"key":"R8-4-20210226","first-page":"255","article-title":"Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts Rheum Dis Clin North Am.","volume":"31","author":"Laskin","year":"2005","journal-title":""},{"key":"R9-4-20210226","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"R10-4-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0049-3848(02)00064-6","article-title":"Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.","volume":"106","author":"Lu","year":"2002","journal-title":"Thromb Res"},{"key":"R11-4-20210226","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R12-4-20210226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3899\/jrheum.100568","article-title":"Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus.","volume":"38","author":"Mehrani","year":"2011","journal-title":"J Rheumatol"},{"key":"R13-4-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R14-4-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/03009740600601526","article-title":"Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus.","volume":"35","author":"Mok","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"R15-4-20210226","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/03009740902776927","article-title":"Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.","volume":"38","author":"Mok","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R16-4-20210226","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R17-4-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.md.0000231955.08350.1b","article-title":"Neuropsychiatric damage in southern Chinese patients with systemic lupus erythematosus.","volume":"85","author":"Mok","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R18-4-20210226","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/rheumatology\/40.8.863","article-title":"Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.","volume":"40","author":"Moss","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R19-4-20210226","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"De Groot PGSubcommittee on Lupus AnticoagulantAntiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus AnticoagulantAntiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R20-4-20210226","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"R21-4-20210226","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R22-4-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus.","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"R23-4-20210226","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism.","volume":"123","author":"White","year":"2009","journal-title":"Thromb Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e31829cae47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:43Z","timestamp":1620963283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201307000-00004"}},"subtitle":["A Cohort Study"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e31829cae47","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}